After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CRDF belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Cardiff Oncology Inc is $155.01M. A total of 1.26 million shares were traded on the day, compared to an average of 1.85M shares.
In the most recent transaction, PACE GARY W bought 275,000 shares of CRDF for 2.45 per share on Jul 30 ’25. After the transaction, the Director now owns 1,330,676 company shares. In a previous transaction on Jul 30 ’25, PACE GARY W bought 15,000 shares at 2.45 per share. CRDF shares that Director owns now total 1,345,676.
Among the insiders who bought shares, Levine James E. acquired of 2,752 shares on Dec 17 ’24 at a per-share price of $5.42. This resulted in the Chief Financial Officer holding 65,316 shares of CRDF after the transaction. In another insider transaction, Levine James E. bought 2,400 shares at $5.00 per share on Dec 18 ’24. Company shares held by the Chief Financial Officer now total 67,716.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CRDF has a high of $5.64 and a low of $2.09.
As of this writing, CRDF has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.23. The company reported an EPS of -$0.25 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CRDF’s latest balance sheet shows that the firm has $140.82M in Cash & Short Term Investments as of fiscal 2021. There were $3.12M in debt and $6.56M in liabilities at the time. Its Book Value Per Share was $0.88, while its Total Shareholder’s Equity was $140.42M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRDF is Buy with a score of 4.71.
